Recently published article on Cyclosporin A toxicity on endothelial cell
Recently published article on the mechanistic toxicology of Cyclosporin A and its effects on angiogenesis November 26th, 2024, Vienna, Austria A recent
By Giulia Corso|2024-11-26T12:15:00+00:00November 26th, 2024|collaboration, EU funded project, iPSCs, publication|
Recently published article on the mechanistic toxicology of Cyclosporin A and its effects on angiogenesis November 26th, 2024, Vienna, Austria A recent
By Giulia Corso|2024-11-04T11:51:47+00:00November 4th, 2024|collaboration, iPSCs, publication|
Recently published article on generating endothelial and vascular smooth muscle cells from PBMC and urine-derived iPSCs November 4th, 2024, Vienna, AustriaA recent
By Giulia Corso|2024-11-04T11:31:45+00:00November 4th, 2024|collaboration, organ-on-a-chip, recent highlights|
Partnering with AIM Biotech November 4th, 2024, Vienna, Austria We are thrilled to announce that we have partnered with Singapore-based AIM
By Giulia Corso|2024-09-26T11:26:47+00:00September 5th, 2024|collaboration, EU funded project, recent highlights, telomerized cells|
New review published by LifeSaver Project Consortium September 5th, 2024, Vienna, Austria The LifeSaver Project Consortium has published a comprehensive review
By Giulia Corso|2024-09-26T11:30:10+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our
By Giulia Corso|2023-09-19T07:33:39+00:00August 4th, 2023|3Rs, collaboration, organ-on-a-chip, RPTEC/TERT1|
Collaboration with Nortis to establish human kidney-on-a-chip model August 4th, 2023. Vienna, Austria Our telomerized Human Renal Proximal Tubular Epithelial cells (RPTEC/TERT1) were used in collaboration with